ASHISH SHAH   

@Ashish_shah72

MS maintains Overweight call on Grasim Ind, target raised to Rs 875/Sh

15/11/2019 08:31:08 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

Citi maintains Buy call on Bharti Airtel on its relatively healthier balance sheet, see EBITDA growing at a 15% CAGR over FY19-22

15/11/2019 08:30:09 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

SGX Nifty levels at 11,920 Vs Nifty Nov Fut's previous close of 11,898, indicating a higher opening on Dalal Street today

15/11/2019 08:27:42 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

SBI LIFE INSURANCE: Rs 55.2cr NSE Block Trade; for ~551994 shares, at Rs 1000

14/11/2019 03:20:31 PM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

JAMNA AUTO INDUSTRIES: Q2 NET PROFIT 63.7M RUPEES VS 355M (YOY); EST 126M || Q2 REVENUE 2.42B RUPEES VS 5.48B (YOY)

14/11/2019 03:20:22 PM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

GAIL INDIA: Rs 23.41cr NSE Block Trade; for ~1941657 shares, at Rs 120.55

14/11/2019 03:07:47 PM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

APOLLO HOSPITALS ENTERPRISE: Q2 NET PROFIT 842.4M RUPEES VS 634M (YOY); EST 1B || Q2 REVENUE 28.41B RUPEES VS 24.12B (YOY)

14/11/2019 03:04:41 PM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

GRASIM INDUSTRIES: Q2 NET PROFIT 5.26B RUPEES VS 6.26B (YOY); EST 6.6B || Q2 REVENUE 47.97B RUPEES VS 51.18B (YOY)

14/11/2019 03:04:21 PM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

POWER FINANCE CORPORATION: Q2 CONS NET PROFIT 18.71B RUPEES VS 16.88B (YOY) || Q2 CONS REVENUE 155.30B RUPEES VS 132.76B (YOY)

14/11/2019 02:52:02 PM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

AUROBINDO PHARMA: Rs 18.13cr NSE Block Trade; for ~464060 shares, at Rs 390.65

14/11/2019 02:22:10 PM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

Vedanta Q2 consolidated net profit at Rs 2,158 cr Vs Rs 1,343 cr (YoY)

14/11/2019 01:47:55 PM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

SUVEN LIFE SCIENCES: Q2 NET PROFIT 723M RUPEES VS 180M (YOY); EST 430M || Q2 REVENUE 2.74B RUPEES VS 895M (YOY)

14/11/2019 01:28:15 PM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

BROKERAGE RADAR MORGAN STANLEY ON CADILA: ET NOW Maintain Overweight, Target at `304/share Earnings concentration is waning for Cadila. Profit base is getting normalized, though gAsacol HD remains Steady growth, IP optionality & reasonable valuation keep us overweight

14/11/2019 08:19:18 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

Macquarie has Outperform call on BHEL, but cuts FY20-22 EPS estimates by 6-7% on lower US, Europe & JV sales

14/11/2019 07:55:40 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

CLSA maintains Buy rating on Cadila Health. It believes even a small positive surprise could drive re-rating

14/11/2019 07:55:24 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

CLSA has a Buy rating on BHEL as it believes govt is looking to unlock value by cutting stakes

14/11/2019 07:55:13 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

Macquarie maintains Neutral call On BHEL with target being cut to Rs 58 From Rs 60/Sh. Upside trigger would stem from cash flows improving

14/11/2019 07:55:04 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

CS has Neutral call on Cadila Health, says Moraiya facility clearance unlikely before H2FY21

14/11/2019 07:54:55 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

CS maintains Outperform rating on BHEL, believes co is placed favourably in orders worth Rs 21,000 cr of which Rs 16,000 cr comes from power

14/11/2019 07:54:43 AM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

SGX Nifty hovers around 11,885 Vs Nifty Nov Fut's yesterday's close of 11,862 indicating a higher opening for the Indian market

14/11/2019 07:54:31 AM     Share:    

---